Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Multiple sclerosis: RBPJ identified as an autoantigen in multiple sclerosis.
Bipolar disorder and multiple sclerosis: A case series.
[Clinically isolated syndrome.]
Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.
Acquired immune demyelinating neuropathies.
Neuromyelitis optica in a child with Aicardi-Goutières syndrome.
Tribute to John F. Kurtzke, MD, FACP, FAAN: 1926-2015.
Therapeutic aspects of cannabis and cannabinoids.
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning.
Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals.
Thermal and motor behavior in experimental autoimmune encephalitis in Lewis rats.
A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation.
Lipopolysaccharide treatment arrests the cell cycle of BV-2 microglial cells in G1 phase and protects them from UV light-induced apoptosis.
Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.
Sexual dysfunction in multiple sclerosis: A 6-year follow-up study.
Multiple sclerosis and family planning.
Psychiatric disorders revealing multiple sclerosis after 20 years of evolvement.
Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients.
Lhermitte's Sign: The Current Status.
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
Therapeutic plasma exchange in the neurologic intensive care setting recommendation for clinical practice.
Prolactin in multiple sclerosis.
Lesion-to-ventricle distance and other risk factors for the persistence of newly formed black holes in relapsing-remitting multiple sclerosis.
Molecular triggers of neuroinflammation in mouse models of demyelinating diseases.
Microtubule-stabilizing agents delay the onset of EAE through inhibition of migration.

Pages